Tetanus
📧 Sign up to get email alerts when something new happens for Tetanus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-10-21Clinical Trial Update: Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents [Phase 4]
Phase 4 immunogenicity study evaluating Adacel and BOOSTRIX vaccines in adolescents has completed with results posted. The sponsor for this …
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Evaluation of Boostrix™10 Years After Previous Booster Vaccination [Phase 4]
Phase 4 trial update evaluating Boostrix 10 years after previous booster vaccination; completed with results posted in 2013.
-
EMA withdrawal · 2013-08-23EMA Lapsed: Infanrix Penta (Diphtheria toxoid;tetanus toxoid;Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin);poliovirus (inactivated) (type 1 (Mahoney strain), type 2 (MEF-1 strain), type 3 (Saukett strain));hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.
EMA status indicates Infanrix Penta is lapsed, with the product no longer active in this market.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™ [Phase 3]
Phase 3 study evaluating a combined DTaP-IPV-HepB-PRP-T vaccine given after a primary series of DTaP-IPV-HepB-PRP-T or Infanrix Hexa; result…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B [Phase 3]
Phase 3 results for Quinvaxem, a pentavalent vaccine against diphtheria, pertussis, tetanus, hepatitis B, and Haemophilus influenzae type B,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-05-22Clinical Trial Update: Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination [Phase 4]
Phase 4 study evaluating whether Quinvaxem can be interchanged with other pentavalent vaccines during routine childhood vaccinations; the tr…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Comparative Study of Two Tetanus Toxoid Vaccination Strategies: Cold Chain Versus Controlled Temperature Chain [NA]
A completed clinical trial comparing cold chain versus controlled temperature chain strategies for tetanus toxoid vaccination.
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine [Phase 3]
Phase 3 trial update on the immunogenicity and safety of Infanrix-IPV+Hib vaccine from GlaxoSmithKline, completed with posted results in 201…
-
CLINICAL_TRIALS trial_result · 2013-03-29Clinical Trial Update: Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in China [Phase 4]
Phase 4 clinical trial assessing the safety of the PENTAXIM pentavalent vaccine given as a three-dose primary series at 2, 3, and 4 months o…
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean Infants [Phase 3]
A Phase 3 immunogenicity study evaluating antibody persistence and booster response of the Pentaxim vaccine in healthy Argentinean infants; …
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine [Phase 3]
Phase 3 trial evaluating the safety and immunogenicity of a serum-free DTaP-IPVvero combination vaccine, completed with results reported by …
-
CLINICAL_TRIALS trial_result · 2012-11-26Clinical Trial Update: Immunogenicity and Safety of Adacel Polio Vaccine [Phase 3]
Phase 3 trial results summarize the immunogenicity and safety of Adacel Polio Vaccine; the study is completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months. [Phase 3]
Phase 3 safety-focused trial comparing the DTaP-IPV-Hep B-PRP~T vaccine to Tritanrix-HepB/Hib and OPV when given at 2, 4, and 6 months.
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older [Phase 4]
This Phase 4 trial evaluated the safety and immunogenicity of the ADACEL vaccine in adults 65 years and older, with results posted in 2012.
-
EMA withdrawal · 2012-08-16EMA Withdrawn: Hexavac (purified diphtheria toxoid;purified tetanus toxoid;purified pertussis toxoid;purified pertussis filamentous haemagglutinin;hepatitis B surface antigen;Inactivated Type 1 Poliovirus (Mahoney);Inactivated Type 3 Poliovirus (Saukett);Haemophilus influenzae type b polysaccharide) — Sanofi Pasteur MSD, SNC
The EMA has withdrawn Hexavac, a hexavalent combination vaccine, from the market. The decision was taken in 2012 and concerns multiple indic…
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Immunogenicity and Safety of Pentaxim in South African Infants [Phase 3]
A Phase 3 clinical trial evaluating the immunogenicity and safety of the Pentaxim vaccine in South African infants has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants. [Phase 3]
A Phase 3 study comparing PENTAXIM with TETRAXIM when co-administered with ACTHIB in South Korean infants has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of Pentaxim given as three-dose primary vaccination with an 18-month booster.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines [Phase 4]
Phase 4 clinical trial assessing immunogenicity and safety of PENTAXIM vaccine in the Philippines for diphtheria, tetanus, poliomyelitis, pe…
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Pentaxim™ in an Indian Population [Phase 3]
Phase 3 trial evaluated immunogenicity and safety of Pentaxim in an Indian population. The study has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV [Phase 3]
Phase 3 trial comparing the immunogenicity and safety of Tetraxim versus local DTP + IPV has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand [Phase 4]
Phase 4 trial assessing immunogenicity and safety of the Sanofi Pasteur Pentaxim combined vaccine in infants in Thailand; the study has comp…
-
CLINICAL_TRIALS trial_result · 2012-01-31Clinical Trial Update: Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine [Phase 3]
Phase 3 trial evaluating safety, immunogenicity, and lot-to-lot comparability of the DTaP vaccine DAPTACEL when administered with other reco…
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy Infants [Phase 3]
This Phase 3 trial compares ACTACEL (DTaP-PRP-T) with separate DTaP and Act-HIB vaccines in healthy infants and has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-13Clinical Trial Update: Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine
A clinical trial update reports antibody persistence in healthy children after primary and booster vaccination with DTaP-IPV-Hep B-PRP-T com…